AAS RAW PHARMA USA
EnglishNederlandsFrançaisDeutschItalianoPolskiРусскийEspañolPortuguês do Brasil

anabolic-androgenic steroid AAS

» anabolic-androgenic steroid AAS

  • Specifications

Testosterone Sustanon 250 Powder 98%+ | Four-Ester Testosterone Blend

Testosterone Sustanon 250 Powder is a premixed raw-material blend modelled on the four testosterone esters associated with Sustanon 250: Testosterone Propionate, Testosterone Phenylpropionate, Testosterone Isocaproate, and Testosterone Decanoate. AAS Raw Pharma offers the blend with a stated overall assay of 98% or higher for qualified laboratory research, analytical evaluation, formulation development, and legally authorised manufacturing.

This product must be described accurately. Sustanon 250 is officially a prescription-only finished oil solution, not a single chemical powder. Therefore, “Testosterone Sustanon 250 Powder” is a commercial description for a blended raw material containing four distinct testosterone esters. It does not represent one pure active pharmaceutical ingredient with a single molecular formula, molecular weight, or individual-compound CAS number.

The intended blend ratio reflects the ester quantities found in a 1 mL ampoule of the finished Sustanon 250 medicine:

  • Testosterone Propionate: 30 mg equivalent
  • Testosterone Phenylpropionate: 60 mg equivalent
  • Testosterone Isocaproate: 60 mg equivalent
  • Testosterone Decanoate: 100 mg equivalent

These quantities create a total of 250 mg of testosterone esters, corresponding to approximately 176 mg of testosterone base equivalent in the official finished medicine. The raw blend offered by AAS Raw Pharma is not the branded medicine and should not be described as a ready-to-use 250 mg/mL injectable.

Important notice: This listing concerns a bulk chemical blend. It is not a finished medicine, sterile injectable solution, dietary supplement, or consumer product, and it is not intended for direct human or veterinary administration. Testosterone esters are controlled or prescription-regulated in many jurisdictions. Buyers are responsible for confirming that purchase, importation, possession, storage, processing, and intended use are lawful.

Testosterone Sustanon 250 Powder Overview

The name Testosterone Sustanon 250 Powder is widely used by raw-material suppliers for a physical mixture of four esterified forms of testosterone. Each ester is a separate chemical substance with its own molecular structure, formula, molecular weight, CAS number, physical characteristics, and analytical profile.

The official Sustanon 250 product is a clear, pale-yellow oil solution containing the four esters in refined arachis oil with benzyl alcohol. Each millilitre contains 30 mg Testosterone Propionate, 60 mg Testosterone Phenylpropionate, 60 mg Testosterone Isocaproate, and 100 mg Testosterone Decanoate. Electronic Medicines Compendium

AAS Raw Pharma’s listing relates instead to the unformulated four-ester blend. It contains no carrier oil or preservative unless expressly stated in the applicable product specification. It has not undergone finished-product formulation, sterilisation, concentration adjustment, container-closure validation, or clinical release testing.

Product Specifications

Specification Product details
Product name Testosterone Sustanon 250 Powder
Product type Premixed four-ester testosterone raw-material blend
Alternative names Sustanon raw powder, Sustanon blend, Testosterone four-ester blend
Stated overall assay 98% minimum, subject to batch documentation
Physical form Powder or crystalline blended solid, subject to batch specification
Number of active components Four separate testosterone esters
Target ester ratio 30:60:60:100 by weight
Ratio expressed as parts 3:6:6:10
Total ratio parts 25
Propionate target fraction 12%
Phenylpropionate target fraction 24%
Isocaproate target fraction 24%
Decanoate target fraction 40%
Single molecular formula Not applicable to a physical mixture
Single molecular weight Not applicable to a physical mixture
Individual compound CAS number Not applicable to the complete blend
Mixture identifier CAS 68924-89-0 appears in some databases for the four-component mixture
Packaging Sealed foil bag, tin, or compatible bulk container
Documentation Batch-specific COA and technical information where available
Intended users Qualified laboratories and legally authorised manufacturers
Direct administration Not permitted; not a finished medicinal product

The precise blend specification must be confirmed in writing before publication or sale. A raw-material supplier should not call a 25:25:25:25 mixture “Sustanon 250” because equal portions do not match the official 30:60:60:100 ester ratio.

Four-Ester Blend Composition

The intended composition can be expressed in several equivalent ways.

Component Official amount per 1 mL finished medicine Target share of total ester mass Ratio parts
Testosterone Propionate 30 mg 12% 3
Testosterone Phenylpropionate 60 mg 24% 6
Testosterone Isocaproate 60 mg 24% 6
Testosterone Decanoate 100 mg 40% 10
Total testosterone esters 250 mg 100% 25

The official finished product reports approximately 176 mg of testosterone base per millilitre, even though the combined ester mass is 250 mg. The difference arises because the stated ester masses include both the testosterone portion and each attached ester group. Electronic Medicines Compendium

For a bulk powder blend, the “250” in the product name denotes the reference composition, not an inherent powder concentration. A powder cannot be described in milligrams per millilitre until it has been formulated into a defined solution.

Component Identity Information

Because this product is a mixture, it should be documented using the identity of every component.

Component CAS number Molecular formula Molecular weight
Testosterone Propionate 57-85-2 C22H32O3 344.49 g/mol
Testosterone Phenylpropionate 1255-49-8 C28H36O3 420.58 g/mol
Testosterone Isocaproate 15262-86-9 C25H38O3 Approximately 386.57 g/mol
Testosterone Decanoate 5721-91-5 C29H46O3 Approximately 442.68 g/mol

NIST and PubChem report CAS 57-85-2, formula C22H32O3, and molecular weight approximately 344.49 for Testosterone Propionate. NIST Chemistry WebBook PubChem

The FDA substance record and LGC Standards report CAS 1255-49-8, formula C28H36O3, and molecular weight 420.58 for Testosterone Phenylpropionate. FDA GSRS LGC Standards

Before publishing the product, AAS Raw Pharma should verify the Isocaproate and Decanoate identifiers against its own component documents and confirm that every batch uses the same four substances.

Is Testosterone Sustanon 250 a Single API?

No. Testosterone Sustanon 250 Powder is not one chemically pure API. It is a physical blend of four APIs or steroidal raw materials.

That distinction affects how the product should be specified and tested:

  • It does not have one molecular formula.
  • It does not have one molecular weight.
  • A single purity result does not prove the correct blend ratio.
  • Every ester must be positively identified.
  • Each component’s quantity or relative proportion must be measured.
  • Uniformity should be demonstrated across representative samples.
  • The blend should be distinguished from the finished oil solution.

PubChem carries an entry for a mixture of Testosterone Decanoate, Testosterone Propionate, Testosterone Phenylpropionate, and Testosterone Isocaproate under CAS 68924-89-0. However, database registration of a mixture does not turn it into a single molecular substance, and the entry’s summed formula should not be presented as the formula of one molecule. PubChem

Raw Blend vs Finished Sustanon 250

Characteristic Testosterone Sustanon 250 Powder Finished Sustanon 250 medicine
Product type Premixed raw-material blend Prescription oil solution
Physical form Powder or crystalline solid blend Clear, pale-yellow oily liquid
Components Four testosterone ester raw materials Four testosterone esters plus excipients
Carrier None unless expressly disclosed Refined arachis oil
Preservative None unless expressly disclosed Benzyl alcohol
Strength Ratio by mass 250 mg of esters per mL
Testosterone equivalent Depends on quantity weighed Approximately 176 mg per mL
Sterility Not implied Finished-product requirement
Ready for injection No Prescription medicine where authorised
Regulatory status Controlled bulk raw material Regulated medicinal product

Official product information describes Sustanon 250 as a solution in refined arachis oil, containing benzyl alcohol, and available only by prescription in the jurisdictions reviewed. Electronic Medicines Compendium Medsafe

This distinction should be stated prominently to prevent customers from mistaking the raw blend for a sterile finished ampoule.

What Does 98%+ Mean for a Four-Component Blend?

For a single substance, an assay may express the percentage of that chemical present. For Testosterone Sustanon 250 Powder, an “overall purity of 98%+” is incomplete unless the test report also shows the identities and proportions of the four esters.

A meaningful release specification should consider:

  • Identity of Testosterone Propionate
  • Identity of Testosterone Phenylpropionate
  • Identity of Testosterone Isocaproate
  • Identity of Testosterone Decanoate
  • Total testosterone ester content
  • Individual ester content
  • Conformity to the 30:60:60:100 target ratio
  • Related substances
  • Residual solvents
  • Water content
  • Blend uniformity
  • Appearance
  • Packaging integrity

If the four ingredients are each at least 98% pure before blending, that does not automatically prove the final mixture is homogeneous or correctly proportioned. Conversely, a single chromatographic purity number cannot confirm that all four intended esters are present in the correct ratio.

Blend Ratio Tolerances

AAS Raw Pharma should establish documented acceptance limits around the 12%, 24%, 24%, and 40% target fractions. Those limits should be based on the actual manufacturing and analytical process rather than copied from another supplier.

A technically useful COA might report each ester as a percentage of total ester mass:

Component Target fraction Batch result
Testosterone Propionate 12.0% Enter actual result
Testosterone Phenylpropionate 24.0% Enter actual result
Testosterone Isocaproate 24.0% Enter actual result
Testosterone Decanoate 40.0% Enter actual result
Total identified ester content At least 98.0% Enter actual result

Do not fill the result column with target values. A target is a manufacturing specification; a result is what the laboratory actually measured.

Appearance and Blend Uniformity

Individual testosterone esters are generally supplied as crystalline solids. Testosterone Propionate, for example, is described as an odourless white or yellowish-white crystalline material, and established reference suppliers list it as a solid or crystalline solid. PubChem Cayman Chemical

The final four-component blend may appear white to off-white, but colour alone cannot confirm:

  • Correct component identity
  • Correct ester ratio
  • Overall purity
  • Homogeneity
  • Absence of cross-contamination
  • Residual-solvent compliance
  • Sterility
  • Suitability for a particular formulation

Physical mixing can also produce segregation if the four components differ in particle size, density, electrostatic behaviour, or flow characteristics. Qualified customers should therefore evaluate representative samples rather than relying on appearance or a single top-of-container test.

Certificate of Analysis

A Certificate of Analysis, or COA, for a multi-component blend should contain more information than a COA for one raw compound. Depending on the agreed specification, it may include:

  • Product name
  • Internal product or catalogue code
  • Batch or lot number
  • Manufacturing and testing dates
  • Appearance
  • Identity of all four esters
  • Individual ester proportions
  • Total identified ester content
  • Related substances
  • Water or loss on drying
  • Residual solvents
  • Test methods
  • Acceptance criteria
  • Actual batch results
  • Retest or expiry information
  • Recommended storage
  • Quality approval

The COA should clearly distinguish between component purity, blend composition, and total assay. Those are related but different quality attributes.

Customers should verify that the lot number on the COA matches the product label. A generic sample COA, another company’s report, or an individual component certificate cannot establish the quality of the final AAS Raw Pharma blend.

Quality-Control Considerations

Depending on the product specification and intended lawful application, evaluation may include:

  • Chromatographic identity and quantification
  • Spectroscopic confirmation
  • Related-substance profiling
  • Residual-solvent analysis
  • Water determination
  • Elemental-impurity assessment
  • Blend-uniformity testing
  • Particle-size evaluation
  • Packaging-integrity inspection
  • Batch traceability

AAS Raw Pharma should only claim HPLC, GC-MS, NMR, FTIR, residual-solvent, heavy-metal, particle-size, sterility, or endotoxin testing when the applicable batch documents show that the test was actually performed.

Raw-material supplier pages make inconsistent claims about “USP grade,” equal 25% component ratios, and 98-99% purity. One listing describes four components at 25% each, which is not the official Sustanon 250 ratio. Another describes the material as a USP-grade single API even though the product is a blend. These competitor claims should not be copied without technical verification.

Grade and Standards

No single “Sustanon 250 Powder USP” monograph was identified in the authoritative sources reviewed. Official product information covers a finished oil solution, while individual testosterone esters may have their own pharmacopoeial monographs or reference standards.

For example, Testosterone Propionate is available as a USP Reference Standard and as material tested according to the European Pharmacopoeia. Sigma-Aldrich USP Sigma-Aldrich Ph. Eur. That does not make an arbitrary four-ester powder blend “USP grade.”

AAS Raw Pharma should describe the product as one of the following, depending on documentation:

  • Four-ester blend manufactured to an internal specification
  • Research-grade testosterone ester mixture
  • Pharmaceutical raw-material blend
  • Custom blend meeting an agreed customer specification

Avoid “USP grade,” “GMP certified,” “sterile,” or “injectable grade” unless those claims are supported by current, product-specific evidence.

Storage of Testosterone Sustanon 250 Powder

Storage instructions for the finished medicine should not be copied automatically onto the raw blend. Official Sustanon 250 ampoules are stored below 30 degrees C, protected from light, and not refrigerated or frozen because they are oil solutions. Electronic Medicines Compendium

Individual raw esters may have different storage requirements. Reference suppliers list refrigerated or frozen conditions for some neat standards: LGC lists below 4 degrees C for its Testosterone Phenylpropionate reference material, while Cayman Chemical lists -20 degrees C for Testosterone Propionate. LGC Standards Cayman Chemical

The correct storage condition for the AAS Raw Pharma blend must therefore come from product-specific stability data, packaging validation, and the applicable COA or SDS.

General professional practice includes:

  • Keep the material in its original, tightly sealed container.
  • Protect it from light and moisture.
  • Avoid repeated temperature changes.
  • Prevent cross-contamination.
  • Store it in a secure, access-controlled area.
  • Keep complete batch and inventory records.
  • Follow the temperature stated on the product label.
  • Keep it away from food, feed, and household products.

Do not publish a shelf life or exact temperature unless it is supported by stability data for the complete four-ester blend.

Safety and Handling

Testosterone esters are biologically active and controlled in many jurisdictions. The blend should be handled only by trained personnel working under an appropriate risk assessment.

Professional controls may include:

  • Restricted access
  • Suitable gloves, protective clothing, and eye protection
  • Dust-control measures
  • Controlled sampling and weighing
  • Appropriate ventilation
  • Dedicated or properly cleaned equipment
  • Cross-contamination prevention
  • Documented spill response
  • Inventory reconciliation
  • Approved disposal procedures

Testosterone Propionate is identified as a Schedule III controlled substance by an established reference supplier, and comparable legal controls may apply to other testosterone ester components and the final blend. Cayman Chemical

The material must not be tasted, swallowed, inhaled deliberately, injected, or applied directly to the body. Keep it away from children and unauthorised persons. Personnel should review the applicable Safety Data Sheet before opening or processing it.

Intended Professional Applications

Subject to local law, customer qualification, and required licences, this blend may be relevant to:

  • Analytical method development
  • Multi-analyte reference work
  • Chemical identity studies
  • Formulation research
  • Blend-uniformity research
  • Impurity and degradation studies
  • Forensic and toxicological research
  • Institutional scientific research
  • Quality-control method evaluation
  • Legally authorised pharmaceutical development

The product’s availability does not authorise a particular application. Each customer must determine whether its organisation, facility, staff, and intended use satisfy all applicable legal and regulatory requirements.

Raw Powder Is Not a Finished Injection

A raw four-ester blend is fundamentally different from the authorised Testosterone Sustanon 250 oil solution. Producing a regulated sterile medicine requires controls that may include:

  • Qualified active ingredients and excipients
  • Validated formulation and mixing procedures
  • Controlled manufacturing facilities
  • Sterility assurance
  • Endotoxin and particulate controls
  • Defined concentration
  • Container-closure validation
  • Stability studies
  • Finished-product release testing
  • Regulatory authorisation

An assay of 98% or higher does not demonstrate sterility, freedom from endotoxins, concentration accuracy in solution, injectable suitability, clinical safety, or regulatory approval.

AAS Raw Pharma does not provide conversion, compounding, solvent, carrier-oil, filtration, sterilisation, injection, dosage, or administration instructions.

Testosterone Sustanon 250 vs Omnadren

The supplied draft uses Sustanon and Omnadren interchangeably. They are related multi-ester testosterone products, but the names should not be treated as automatically identical.

Product compositions have varied by brand, manufacturer, market, and historical formulation. A page specifically selling a blend modelled on Testosterone Sustanon 250 should define its own four components and ratio instead of relying on Omnadren as a synonym.

For search optimisation, Omnadren may be mentioned once as a related multi-ester testosterone product, but it should not be placed in the product title, principal specification, or schema unless the AAS Raw Pharma blend is genuinely designed and documented to match a named Omnadren formulation.

Packaging Options

Packaging should protect the mixed powder from light, moisture, contamination, segregation, and physical damage. Possible options include:

  • Sealed foil bags
  • Tins or rigid secondary containers
  • Tamper-evident closures
  • Protective inner packaging
  • Labelled commercial packs
  • Approved bulk containers
  • Custom quantities by agreement

Every package should identify the product as a four-component blend and include the batch number, quantity, storage conditions, and relevant handling information.

Packaging and customs documentation must describe the goods accurately. AAS Raw Pharma does not offer disguised, falsely declared, or deliberately mislabelled shipments.

Sample and Bulk Supply

Samples may be available to qualified laboratories, institutions, and authorised manufacturers, subject to inventory, destination law, customer verification, and intended use.

For a quotation, provide:

  1. Product name
  2. Required quantity
  3. Destination country
  4. Registered company or institution
  5. Intended lawful application
  6. Required ester ratio
  7. Minimum overall assay
  8. Required quality tests
  9. Preferred packaging
  10. Required permits and documentation

Availability, minimum order quantity, production capacity, price, and lead time should be confirmed in a formal quotation. Do not advertise “free samples” unless that offer is current, qualified, and governed by clear terms.

Why Choose AAS Raw Pharma?

AAS Raw Pharma supports qualified customers seeking documented steroidal raw materials for lawful professional applications.

Defined Four-Ester Composition

The intended blend follows a clearly stated 30:60:60:100 ratio rather than an ambiguous “mixed testosterone” description.

Stated 98%+ Overall Assay

The product carries a stated minimum overall assay of 98%, subject to the results and methods documented for the supplied batch.

Batch Documentation

Customers may request the available COA, specification, SDS, and supporting technical records before purchase.

Factory-Direct Commercial Supply

Direct sourcing can support competitive quotations for approved development and bulk requirements. Final price depends on quantity, testing, packaging, availability, and destination.

Custom Specification Review

Qualified customers can discuss ratio tolerances, documentation, packaging, and testing requirements before the order is accepted.

Secure, Traceable Packaging

Packaging can be selected to protect the blend and preserve batch identification throughout lawful storage and transportation.

International Enquiry Support

The sales team can assess logistics options for destinations where exportation, transportation, importation, possession, and intended use are lawful.

Responsive After-Sales Service

Support is available for order records, specifications, batch documentation, packaging, and shipment enquiries. Any discrepancy should be reported with the relevant order and batch information.

International Shipping and Compliance

International delivery may be assessed where the transaction and shipment are lawful and accepted by an appropriate carrier. Potential logistics providers may include DHL, FedEx, UPS, TNT, EMS, or a specialist freight service, depending on destination, quantity, classification, and documentation.

The buyer is responsible for confirming:

  • Import eligibility
  • Customs classification
  • Controlled-substance restrictions
  • Pharmaceutical or research licences
  • End-user declarations
  • Secure-storage obligations
  • Carrier acceptance
  • Duties and taxes
  • Inventory and disposal requirements

AAS Raw Pharma does not guarantee customs clearance and does not support false descriptions, values, labels, invoices, or declarations.

Statements to Remove From the Original Draft

Remove or rewrite Reason
“Sustanon 250 injection form” as the product identity The listed product is raw powder, not finished injection
“Ideal compound for putting on size and increasing strength” Bodybuilding and performance claim
“Perfect remedy” for low testosterone Unqualified medical claim
Descriptions of physical, mental, and sexual symptoms Medical marketing unrelated to raw-material specification
Performance-athlete comparisons Encourages non-medical use
“Effective dose: 250-1,000 mg/week” High-risk dosing guidance
“Effective dose for women: not recommended” Personal-use dosing context
Cycle reviews, active-life, and detection-time fields Doping and self-administration content
Injection-frequency recommendations Administration guidance
“500-1,000 mg per week” discussion Unsafe performance-enhancement instructions
“Quality guarantee 100%” Absolute claim not substantiated by a batch report
“100% custom rate” Unclear and unverifiable
“Well disguised packing” Suggests customs or detection evasion
Guaranteed fast delivery to named countries May be false where import controls apply

Important Medical and Use Disclaimer

This page provides technical and commercial information about a controlled raw-material blend. It does not recommend Testosterone Sustanon 250 Powder for testosterone replacement, bodybuilding, muscle gain, strength enhancement, athletic performance, or any personal application.

No dosage, injection, cycle, stacking, treatment, or detection-time guidance is included. Those details are inappropriate for a bulk raw material and could facilitate unsafe or unlawful use.

Any legitimate treatment of testosterone deficiency requires clinical diagnosis, medical supervision, and a lawfully authorised finished medicine. The official Testosterone Sustanon 250 product is prescription-only in the jurisdictions reviewed. Medsafe Healthdirect

Frequently Asked Questions

What is Testosterone Sustanon 250 Powder?

Testosterone Sustanon 250 Powder is a commercial name for a blended raw material containing Testosterone Propionate, Testosterone Phenylpropionate, Testosterone Isocaproate, and Testosterone Decanoate.

Is Sustanon 250 a single chemical compound?

No. It is a mixture of four separate testosterone esters and therefore does not have one molecular formula or one molecular weight.

What is the intended blend ratio?

The intended ratio is 30:60:60:100, equivalent to 12%, 24%, 24%, and 40% by total ester mass.

Why is it called “250”?

The official finished medicine contains a total of 250 mg of the four testosterone esters per millilitre. For raw powder, “250” refers to that model composition and is not itself a concentration.

Does 250 mg of esters equal 250 mg of testosterone?

No. Official product information states that 250 mg of the four esters corresponds to approximately 176 mg of testosterone base. Electronic Medicines Compendium

What is the purity?

AAS Raw Pharma lists a stated overall assay of 98% or higher, subject to batch-specific documentation. The COA should also report the identity and proportion of each ester.

Does the mixture have a CAS number?

PubChem associates CAS 68924-89-0 with a mixture containing the four esters. The individual component CAS numbers should still appear in the technical documentation.

Is it the same as the branded Sustanon 250 injection?

No. The branded product is a prescription oil solution containing the four esters, refined arachis oil, and benzyl alcohol. The AAS Raw Pharma listing concerns an unformulated raw blend.

Does the powder contain arachis oil?

Not unless the product specification expressly says so. A dry blend should contain the four raw ester components and no carrier oil or preservative.

Is it sterile?

Sterility must not be assumed. Unless an exact batch has been manufactured, tested, and released to a documented sterile specification, it must be treated as non-sterile raw material.

Is the powder ready for injection?

No. It is not a finished, sterile, concentration-adjusted, or authorised injectable medicine.

Is a Certificate of Analysis available?

Batch documentation may be available on request. Buyers should confirm that the COA reports each component’s identity, proportion, and the overall assay.

How should the blend be stored?

Follow the exact conditions on the AAS Raw Pharma label, COA, and SDS. Conditions for the finished oil solution should not automatically be applied to the raw powder.

Is a sample available?

Samples may be available to qualified customers, subject to inventory, verification, intended use, destination law, and commercial terms.

Is bulk supply available?

Bulk enquiries may be reviewed according to quantity, component availability, testing requirements, customer qualification, and destination regulations.

Can AAS Raw Pharma ship internationally?

International delivery may be possible where exportation, transportation, importation, possession, and intended use are lawful.

Is customs clearance guaranteed?

No. The purchaser is responsible for permits, declarations, duties, taxes, and destination-country requirements.

Does AAS Raw Pharma provide dosage or cycle instructions?

No. Dosage, injection, cycle, stacking, and performance-use instructions are inappropriate for a bulk raw material.

How can I request a quotation?

Provide the quantity, destination, organisation details, intended lawful use, required ratio, assay, packaging, documentation, and applicable permits.

 

 

Table of Content

Enquiry Form ( we will get back you as soon as possible )

Name:
*
Email:
*
Message:

Verification:
1 + 7 = ?

Maybe you like also